Neuropeptide G Protein-Coupled Receptors as Oncotargets
Related Experiment Video
Updated: Feb 7, 2026

Quantifying Agonist Activity at G Protein-coupled Receptors
Published on: December 26, 2011
Terry W Moody1, Irene Ramos-Alvarez2, Robert T Jensen2
1Department of Health and Human Services, National Cancer Institute, Center for Cancer Research, National Institute of Diabetes, Digestive, and Kidney Disease (NIDDK), Bethesda, MD, United States.
Abstract:
Neuropeptide G protein-coupled receptors (GPCRs) are overexpressed on numerous cancer cells. In a number of tumors, such as small cell lung cancer (SCLC), bombesin (BB) like peptides and neurotensin (NTS) function as autocrine growth factors whereby they are secreted from tumor cells, bind to cell surface receptors and stimulate growth. BB-drug conjugates and BB receptor antagonists inhibit the growth of a number of cancers. Vasoactive intestinal peptide (VIP) increases the secretion rate of BB-like peptide and NTS from SCLC leading to increased proliferation. In contrast, somatostatin (SST) inhibits the secretion of autocrine growth factors from neuroendocrine tumors (NETs) and decreases proliferation. SST analogs such as radiolabeled octreotide can be used to localize tumors, is therapeutic for certain cancer patients and has been approved for four different indications in the diagnosis/treatment of NETs. The review will focus on how BB, NTS, VIP, and SST receptors can facilitate the early detection and treatment of cancer.
Insights
Neuropeptide receptors like bombesin and neurotensin promote cancer growth, while somatostatin inhibits it. Targeting these receptors offers new avenues for cancer detection and treatment.
Area of Science:
- Oncology
- Molecular Endocrinology
- G protein-coupled receptor (GPCR) signaling
Background:
- Neuropeptide G protein-coupled receptors (GPCRs) are frequently overexpressed in various cancer types.
- In small cell lung cancer (SCLC), bombesin (BB) and neurotensin (NTS) peptides act as autocrine growth factors, stimulating tumor cell proliferation.
- Vasoactive intestinal peptide (VIP) can enhance BB-like peptide and NTS secretion, further promoting SCLC growth.
Purpose of the Study:
- To review the role of neuropeptide receptors in cancer.
- To explore how bombesin (BB), neurotensin (NTS), vasoactive intestinal peptide (VIP), and somatostatin (SST) receptors can be leveraged for cancer diagnosis and therapy.
- To highlight the therapeutic potential of targeting these receptor pathways.
Main Methods:
- Literature review focusing on neuropeptide receptor function in cancer.
- Analysis of studies investigating BB, NTS, VIP, and SST receptor roles in tumor growth and proliferation.
- Examination of therapeutic strategies involving receptor antagonists, drug conjugates, and receptor analogs.
Main Results:
- BB and NTS receptor activation stimulates cancer cell growth, with BB-drug conjugates and antagonists showing inhibitory effects.
- Somatostatin (SST) inhibits autocrine growth factor secretion in neuroendocrine tumors (NETs), reducing proliferation.
- SST analogs, like radiolabeled octreotide, are valuable for tumor localization, diagnosis, and treatment of NETs.
Conclusions:
- Neuropeptide receptors represent promising targets for novel cancer therapies.
- Targeting BB, NTS, VIP, and SST receptors offers potential for early cancer detection and effective treatment strategies.
- The dual role of these receptors in promoting or inhibiting cancer highlights their significance in oncology.
Related Concept Videos
G-protein Coupled Receptors
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Transducer Mechanism: G Protein–Coupled Receptors
GPCRs are also called heptahelical,...
Internal Receptors
Spin–Spin Coupling: Two-Bond Coupling (Geminal Coupling)
The central atom need not be NMR-active because its electrons are affected by the electron polarization of the spin-active atoms. However, spin information is transmitted less effectively than in one-bond coupling, and 2J values are usually weaker than 1J values. The energy of...
Spin–Spin Coupling: Three-Bond Coupling (Vicinal Coupling)
The extent of coupling depends on the C‑C bond length, the two H‑C‑C angles, any electron-withdrawing substituents, and the dihedral angle between the involved orbitals. The...

